Brief: Diaxonhit and CareDx successfully transfer AlloMap test to Europe
Jan 13 (Reuters) - Diaxonhit SA ALEHT.PA :
* Diaxonhit and CareDx announce the successful transfer of
AlloMap test to Europe
* Validation is transferred to the central immunology
laboratory of the University Hospital in Strasbourg, France
Source text for Eikon: urn:newsml:reuters.com:*:nHUG3q3RnK
Further company coverage: ALEHT.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on Eurobio Scientific SA
See all newsBrief: Eurobio Scientific EB Development Files Public Offer For Shares
Brief: Eurobio Scientific Says At End Of June 2024, Recorded Revenues Of 73.4 Mln Euros, Compared With 59.1 Mln Euros A Year Ago
Brief: Eurobio Scientific FY Core Business Revenues Up At EUR 130 Mln
Brief: Eurobio Scientific Cancels 694,300 Treasury Shares, Representing Around 6.34% Of Share Capital
Brief: Eurobio Scientific H1 Ebitda Up To EUR 13.4 Million